 |
PGC-C12E-terlipressin |
|---|---|
| Trade Name | |
| Orphan Indication | Refractory ascites due to all etiologies except for cancer |
| USA Market Approval | USA |
| USA Designation Date | 2012-12-27 00:00:00 |
| Sponsor | PharmaIN Corporation;19805 N. Creek Pkwy, Suite 200;Bothell, WA, 98011 |
